vs

Side-by-side financial comparison of LIVEPERSON INC (LPSN) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

LIVEPERSON INC is the larger business by last-quarter revenue ($59.3M vs $57.3M, roughly 1.0× RHYTHM PHARMACEUTICALS, INC.). LIVEPERSON INC runs the higher net margin — -77.8% vs -83.0%, a 5.2% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -19.0%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -16.6%).

LivePerson is a global technology company that develops conversational commerce and AI software.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

LPSN vs RYTM — Head-to-Head

Bigger by revenue
LPSN
LPSN
1.0× larger
LPSN
$59.3M
$57.3M
RYTM
Growing faster (revenue YoY)
RYTM
RYTM
+55.9% gap
RYTM
36.9%
-19.0%
LPSN
Higher net margin
LPSN
LPSN
5.2% more per $
LPSN
-77.8%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
-16.6%
LPSN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LPSN
LPSN
RYTM
RYTM
Revenue
$59.3M
$57.3M
Net Profit
$-46.1M
$-47.5M
Gross Margin
73.2%
91.6%
Operating Margin
-68.7%
-82.2%
Net Margin
-77.8%
-83.0%
Revenue YoY
-19.0%
36.9%
Net Profit YoY
58.9%
-9.6%
EPS (diluted)
$-9.22
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LPSN
LPSN
RYTM
RYTM
Q4 25
$59.3M
$57.3M
Q3 25
$60.2M
$51.3M
Q2 25
$59.6M
$48.5M
Q1 25
$64.7M
$32.7M
Q4 24
$73.2M
$41.8M
Q3 24
$74.2M
$33.3M
Q2 24
$79.9M
$29.1M
Q1 24
$85.1M
$26.0M
Net Profit
LPSN
LPSN
RYTM
RYTM
Q4 25
$-46.1M
$-47.5M
Q3 25
$8.7M
$-52.9M
Q2 25
$-15.7M
$-46.6M
Q1 25
$-14.1M
$-49.5M
Q4 24
$-112.1M
$-43.3M
Q3 24
$-28.3M
$-43.6M
Q2 24
$41.8M
$-32.3M
Q1 24
$-35.6M
$-141.4M
Gross Margin
LPSN
LPSN
RYTM
RYTM
Q4 25
73.2%
91.6%
Q3 25
71.4%
89.3%
Q2 25
69.7%
88.6%
Q1 25
71.8%
88.8%
Q4 24
77.4%
90.9%
Q3 24
73.1%
88.5%
Q2 24
79.4%
89.9%
Q1 24
71.3%
89.2%
Operating Margin
LPSN
LPSN
RYTM
RYTM
Q4 25
-68.7%
-82.2%
Q3 25
-24.2%
-102.6%
Q2 25
-10.8%
-93.4%
Q1 25
-26.2%
-143.7%
Q4 24
-138.0%
-98.6%
Q3 24
-21.6%
-132.0%
Q2 24
-37.3%
-139.2%
Q1 24
-42.7%
-538.7%
Net Margin
LPSN
LPSN
RYTM
RYTM
Q4 25
-77.8%
-83.0%
Q3 25
14.5%
-103.1%
Q2 25
-26.4%
-96.1%
Q1 25
-21.8%
-151.4%
Q4 24
-153.2%
-103.6%
Q3 24
-38.1%
-131.2%
Q2 24
52.3%
-110.9%
Q1 24
-41.8%
-544.4%
EPS (diluted)
LPSN
LPSN
RYTM
RYTM
Q4 25
$-9.22
$-0.73
Q3 25
$-2.76
$-0.82
Q2 25
$-0.17
$-0.75
Q1 25
$-0.24
$-0.81
Q4 24
$-17.23
$-0.71
Q3 24
$-4.74
$-0.73
Q2 24
$-0.33
$-0.55
Q1 24
$-0.40
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LPSN
LPSN
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$95.0M
$388.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-44.5M
$139.1M
Total Assets
$454.7M
$480.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LPSN
LPSN
RYTM
RYTM
Q4 25
$95.0M
$388.9M
Q3 25
$106.7M
$416.1M
Q2 25
$162.0M
$291.0M
Q1 25
$176.3M
$314.5M
Q4 24
$183.2M
$320.6M
Q3 24
$142.1M
$298.4M
Q2 24
$146.0M
$319.1M
Q1 24
$127.1M
$201.2M
Total Debt
LPSN
LPSN
RYTM
RYTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$512.1M
Stockholders' Equity
LPSN
LPSN
RYTM
RYTM
Q4 25
$-44.5M
$139.1M
Q3 25
$-22.1M
$148.8M
Q2 25
$-82.4M
$-11.9M
Q1 25
$-74.9M
$18.9M
Q4 24
$-67.3M
$21.7M
Q3 24
$45.9M
$11.2M
Q2 24
$66.6M
$39.3M
Q1 24
$19.2M
$61.6M
Total Assets
LPSN
LPSN
RYTM
RYTM
Q4 25
$454.7M
$480.2M
Q3 25
$511.4M
$506.9M
Q2 25
$604.2M
$372.7M
Q1 25
$596.2M
$386.7M
Q4 24
$607.8M
$392.3M
Q3 24
$692.0M
$363.6M
Q2 24
$703.8M
$381.8M
Q1 24
$724.7M
$258.7M
Debt / Equity
LPSN
LPSN
RYTM
RYTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
26.69×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LPSN
LPSN
RYTM
RYTM
Operating Cash FlowLast quarter
$-9.7M
$-25.4M
Free Cash FlowOCF − Capex
$-12.0M
FCF MarginFCF / Revenue
-20.2%
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LPSN
LPSN
RYTM
RYTM
Q4 25
$-9.7M
$-25.4M
Q3 25
$-6.0M
$-26.6M
Q2 25
$-11.7M
$-23.3M
Q1 25
$-3.1M
$-40.4M
Q4 24
$-3.1M
$-18.8M
Q3 24
$4.8M
$-25.2M
Q2 24
$-17.9M
$-29.1M
Q1 24
$1.1M
$-40.7M
Free Cash Flow
LPSN
LPSN
RYTM
RYTM
Q4 25
$-12.0M
Q3 25
$-8.9M
Q2 25
$-14.8M
Q1 25
$-6.9M
Q4 24
$-6.8M
Q3 24
$-230.0K
Q2 24
$-22.9M
Q1 24
$-10.4M
FCF Margin
LPSN
LPSN
RYTM
RYTM
Q4 25
-20.2%
Q3 25
-14.8%
Q2 25
-24.9%
Q1 25
-10.6%
Q4 24
-9.2%
Q3 24
-0.3%
Q2 24
-28.7%
Q1 24
-12.2%
Capex Intensity
LPSN
LPSN
RYTM
RYTM
Q4 25
3.9%
Q3 25
4.8%
Q2 25
5.3%
Q1 25
5.8%
Q4 24
5.0%
Q3 24
6.8%
Q2 24
6.2%
Q1 24
13.5%
Cash Conversion
LPSN
LPSN
RYTM
RYTM
Q4 25
Q3 25
-0.69×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-0.43×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LPSN
LPSN

Hosted Services Business$51.0M86%
Professional Services$8.3M14%

RYTM
RYTM

Segment breakdown not available.

Related Comparisons